S H Kelkar & Co.

NSE: SHK · Specialty Chemicals

52W Range₹112 ₹276

Snapshot

Unlock S H Kelkar & Co.'s vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

S H Kelkar and Company Limited is a prominent manufacturer and supplier of fragrances, flavours, and aroma ingredients. The company serves a diverse range of industries, including personal care, household products, food and beverage, and pharmaceuticals, operating under brands such as SHK, Cobra, and Keva.

Business Model

The company generates revenue by developing and supplying customised fragrance and flavour solutions to national and multinational FMCG companies. It leverages its long-standing expertise in aroma ingredients to cater to both domestic and international markets.

  • Founded:1914

Growth Outlook

Growth is driven by the increasing demand for fragrance and flavour applications in the expanding Indian FMCG sector. The company continues to focus on strengthening its product portfolio and expanding its footprint in both domestic and export markets.

Key Risks

  • Raw Material Price Volatility. Fluctuations in the cost of essential oils and aroma chemicals can significantly impact operating margins.
  • Regulatory Compliance. The company must adhere to stringent international safety and quality standards for food and personal care ingredients.
  • Competitive Intensity. The fragrance and flavour industry is highly competitive, requiring continuous innovation to maintain market share against global players.
  • Currency Risk. As an exporter, the company is exposed to foreign exchange rate fluctuations that may affect profitability.

Price

Start your research today

Unlock AI insights, financials, peers and live data on S H Kelkar & Co. and 5,000+ companies — free.

Start your research

Key Metrics

REVENUE

₹2,368 Cr

TTM · consolidated

+11.5%YoY

NET PROFIT

₹69 Cr

TTM · consolidated

-5.3%YoY

EPS

₹5.00

TTM · consolidated

-6.7%YoY

RETURN ON EQUITY

5.3%

TTM · consolidated

-0.6 ppYoY

RETURN ON CAPITAL EMPLOYED

10.5%

TTM · consolidated

-0.6 ppYoY

P/E

25.8x

Q4 FY26 · consolidated

25.8 vs 26.4x5Y avg

EV/EBITDA

10.2x

Q4 FY26 · consolidated

10.2 vs 13.4x5Y avg

EBITDA MARGIN

10.6%

TTM · consolidated

-4.5 ppYoY

NET PROFIT MARGIN

0.3%

Q4 FY26 · consolidated

-17.8 ppYoY

DEBT TO EQUITY

0.6x

Q4 FY26 · consolidated

+0.03xYoY

Peers · Specialty Chemicals

CompanyMkt Cap (Cr)P/EEV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
S H Kelkar & Co.SHK
1,80625.8310.2411.5%10.6%5.3%10.5%-46.6%
Camlin Fine Sciences LimitedCAMLINFINE
2,192-77.1221.814.5%7.7%2.5%3.0%-57.1%
Bhansali Engg.BEPL
2,13715.159.18-8.7%20.0%17.6%23.7%-3.8%
Yasho IndustriesYASHO
1,799125.1723.3053.9%17.3%6.8%14.2%+50.2%
Titan BiotechTITANBIO
1,66514.1239.3534.5%21.3%18.6%23.7%-8.0%
Godavari Bioref.GODAVARIB
1,56611.177.5312.3%15.2%19.3%-14.6%

As of Q4 FY26

Financials